Ayrton Capital’s PepperLime Health Acquisition Corporation Unit PEPLU Stock Holding History
Bought
Maintained
Sold
Other funds holding PEPLU
SIM
MF
ACM
BFM
CIM
WC
SMA
SIA
LCM
Ayrton Capital's PEPLU Position: Q1 2022 in Review
Ayrton Capital sold out of PepperLime Health Acquisition Corporation Unit (PEPLU) in Q1 2022, closing a stake of 13,028 shares — an estimated $133K sold.
Ayrton Capital first reported a position in PEPLU in Q4 2021 and held it in 1 quarter. The position peaked at $133K in Q4 2021. 15 funds tracked by Wall St. Rank hold PEPLU as of Q1 2022.
- Ayrton Capital reported no remaining PepperLime Health Acquisition Corporation Unit position as of Q1 2022 after selling out during the quarter.
- Ayrton Capital sold 13,028 PepperLime Health Acquisition Corporation Unit shares in Q1 2022, an estimated $133K.
- Ayrton Capital first reported a position in PepperLime Health Acquisition Corporation Unit in Q4 2021 and held it in 1 quarter.
- Ayrton Capital's PepperLime Health Acquisition Corporation Unit position peaked at $133K in Q4 2021.
- 15 funds tracked by Wall St. Rank held PepperLime Health Acquisition Corporation Unit as of Q1 2022.
Based on Ayrton Capital's 13F filing for Q1 2022, filed 12 May 2022.